alpha-aminopyridine has been researched along with Adenocystic Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, M; Li, C; Li, H; Lin, F; Meng, X; Nan, P; Qian, H; Wang, H; Wang, T; Yang, S; Zhang, X; Zhou, C | 1 |
| Huang, P; Liu, X; Wu, H; Zhang, F | 1 |
2 other study(ies) available for alpha-aminopyridine and Adenocystic Carcinoma
| Article | Year |
|---|---|
Inhibitory effect of chidamide on the growth of human adenoid cystic carcinoma cells.
Topics: Aminopyridines; Animals; Antineoplastic Agents; Apoptosis; Benzamides; Carcinoma, Adenoid Cystic; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cisplatin; Dose-Response Relationship, Drug; Histone Deacetylase Inhibitors; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Time Factors; Up-Regulation; Xenograft Model Antitumor Assays | 2018 |
JQ1 and PI3K inhibition synergistically reduce salivary adenoid cystic carcinoma malignancy by targeting the c-Myc and EGFR signaling pathways.
Topics: Aminopyridines; Apoptosis; Azepines; Carcinoma, Adenoid Cystic; Cell Cycle Proteins; Cell Proliferation; Cell Survival; Drug Synergism; Drug Therapy, Combination; ErbB Receptors; Gene Expression; Humans; Molecular Targeted Therapy; Morpholines; Nuclear Proteins; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-myc; Salivary Gland Neoplasms; Signal Transduction; Transcription Factors; Triazoles; Tumor Cells, Cultured | 2019 |